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Summary 
 
The midbrain dopaminergic (mDA) neurons constitute about 75% of 
dopaminergic neurons in the adult brain. These neurons are involved 
in the control of voluntary movements and in the regulation of emotion-
related behaviour. Loss of mDA neurons can cause Parkinson’s 
disease and other neurological disorders as well. In order to 
understand the selective degeneration of these neurons, insight in the 
pathways and factors involved in the development and maintenance of 
this subset of dopaminergic neurons is needed. On the other hand, the 
prospect of using stem–cell derived DA neurons has emphasized the 
requirement of understanding the normal pathway of DA neuron 
development. Among the factors implicated in mDA neuron 
development are Wnt1, Wnt5a, En1/2, Otx2, Foxa1, Foxa2, Ngn2, 
Nurr1, Pitx3, Msx1 and LIM homeodomain transcription factors Lmx1a 
and Lmx1b. 
Several studies suggested a role for Lmx1a in establishing a mDA 
neuronal phenotype (Andersson et al., 2006; Chung et al.,2009). Gain 
and loss of function studies in chick revealed that Lmx1a is required for 
the specification of mDA neurons. Furthermore Lmx1a can induce 
mouse embryonic stem (mES) cells  into DA neurons. Together these 
experiments in chick and in mES cells suggest an essential role for 
Lmx1a in determination of mDA neurons.  
Beside several studies suggesting a role for Lmx1a in proliferation and 
neurogenesis, the precise role of Lmx1a in the mouse mDA is still not 
fully understood. 
Therefore, to understand the Lmx1a phenotype in depth we studied 
the gain of function of Lmx1a in NesE-Lmx1a gain of function cell line. 
In this cell line Lmx1a is under the control of the enhancer of Nestin. 
Using NesE-Lmx1a cell line Andersson and colleagues (Andersson et 
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al., 2006) showed that Lmx1a functions as DA neuron determinant for 
midbrain dopamine neurons in mES cells. 
We were interested to know the molecular network that Lmx1a 
activates to do that. To elucidate the molecular programming we 
performed qPCR analysis on d5 and d9 NesE-Lmx1a cells. 
RT-qPCR analysis at d5 showed that several genes involved in 
midbrain dopamine neuron specification, differentiation and migration 
such as Ngn2, Foxa2, Nurr1, Rspo2, Slit2, Aldh1a1 were upregulated. 
At d9 qPCR results showed that Tuj1, which is used as marker for 
postmitotic neuronal cells was upregulated in NesE-Lmx1a compared 
with control cells and so Nurr1. 
Altogether these data indicate that Lmx1a is essential for the correct 
development of mDA neurons and it does that by regulating the 
expression of of several genes involved in dopamine neuron 
differentiation and migration. 	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1.Introduction 
 
1.1 Dopamine neuron systems in the central nervous 
system 
 
Dopamine (DA) is one of the catecholaminergic neurotransmitters of 
the vertebrate central nervous system (CNS), where it is synthesized 
in a common biosynthetic pathway as a precursor to noradrenaline and 
adrenaline. Tyrosine hydroxylase (TH) is the first and rate-limiting 
enzyme of this pathway that converts the essential amino acid tyrosine 
to L-dihydroxy-phenylalanine (L-DOPA). L-DOPA is then 
decarboxylated by the enzyme L-aromatic amino acid decarboxylase 
(Aadc/Ddc) to produce dopamine (Figure 1). Dopamine neuron system 
was first described in the early 1960’s, as part of the catecholaminergic 
system using the formaldehyde histofluorescence method (Jonsson, 
1967).  
 
 
 
 
 
Figure 1. Dopamine synthesis pathway. In the cytoplasm of the dopaminergic 
neuron tyrosine is converted into dihydroxyphenylalanine (DOPA) by the tyrosine 
hydroxylase (TH) enzyme. DOPA is then converted to dopamine in the cytoplasm 
by the enzyme aromatic L-amino acid decarboxylase (Aadc). 
 
With the introduction of immunohistochemistry method TH expression 
has been used as a molecular marker for the DA-synthesizing 
neurons. TH expression has revealed 9 major dopaminergic nuclei 
(A8-A16) during embryonic development and in adults in mammalian 
CNS, distributed from the mesencephalon to the olfactory bulb (Figure 
2). The dopaminergic nuclei are named: mesodiencephalic tegmental 
(A8-A10) nuclei, the caudal mesodiencephalic periacquaductal grey 
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(A11) nucleus, the hypothalamic (A12, A14, A15) nuclei, the zona 
incerta (A13) nuclei in the ventral thalamus and dendritic 
periglomerular (A16) neurons. Despite the fact that these neurons 
share neurotransmitter identity they project to distinct areas of the 
central nervous system and have different functions. 
Since midbrain dopamine neurons (mDA neurons) are associated with 
Parkinson’s disease and other mental disorders, they have been a 
focus of clinical interest and a subject of intensive studies for several 
years, decades.  
TH+ mDA neurons (A8-A10) originate from the ventral part of a domain 
of the brain that extends rostrally to the ventral thalamus/hypothalamus 
border and caudally to the midbrain hindbrain border. mDA neurons 
are involved in the control of voluntary movements and in the 
regulation of emotion related behavior. These neurons represent about 
75% of dopaminergic neurons in the adult brain and are anatomically 
divided into three main subgroups.  
 
 
 
 
 
 
 
 
Figure 2. Distribution of dopaminergic cell groups in the developing (a) and 
adult (b) rodent brain. The nine subgroups of dopamine neurons A8-16 are 
distributed from mesecenphalon to telencephalon. Midbrain dopamine neurons (A8-
A10) project to the striatum and the limbic areas through the cortico-limbic and 
nigrostriatal pathway respectively (Björklund and Dunnett, 2007). 
 
The lateral A9 group correspond to the substantia nigra pars compacta 
neurons (SNpc) which mainly project into the dorsal striatum via the 
nigro-striatal pathway (Figure 1). Cells of the SNpc are involved in the 
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control of voluntary movements and postural reflexes. The progressive 
degeneration of SNpc neurons in the adults leads to Parkinson’s 
disease. The median A10 and lateral A8 neuron groups define 
respectively the ventral tegmental area (VTA) and the retrorubral field 
(RRF) of the midbrain. A10 and A8 groups project to the ventromedial 
striatum as part of mesocortical limbic system that is involved in 
emotional behavior and reward mechanisms (Dalhstrom and Fuxe, 
1964; Tzschentke and Schmidt, 2000). Dysregulation of DA 
transmission in the limbic system has been linked to the development 
of drug addiction (Kelly and Berridge, 2002; Wightman and Robinson, 
2002), depression (Dailly et al., 2004) and is thought to contribute to 
the psychotic symptoms of schizophrenia (Sesack and Carr, 2002). 
 
1.2 Specification of midbrain dopamine neuronal field  
 
The specification of the permissive region for dopamine neuron 
generation is a fundamental event that occurs early in mDA neuronal 
development. Initial CNS division occurs through the formation and 
positioning of molecular borders including the midbrain-hindbrain 
border (MHB), known as the isthmus organizer, which is essential for 
the specification of the mDA neuronal field. The axial positioning of the 
MHB is established and maintained by fibroblast growth factor 8 
(FGF8) expression and co-repressive interactions of Otx2 and Gbx2. 
The formation of the isthmus, which produces FGF8, together with 
sonic hedgehog (SHH) signalling from the notochord designates, at a 
specific region where these signals intersect each other the region 
where midbrain dopamine neurons are born.  
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Figure 3. Scheme of the neural tube and molecular determinants inducing 
midbrain dopamine fate. Inductive signals of Shh and Fgf8 which arise from the 
notochord (grey circle) and the midbrain-hindbrain border (blue), combined with Otx2 
expression establish midbrain ventral cell identity (modified from Gale & Li 2008). 
 
Transforming growth factor- β (TGFβ) is essential for the early SHH 
signalling and subsequent induction of mDA region. WNT signalling 
(WNT1 and WNT5A) is decisive for the establishment of midbrain-
hindbrain region and is involved in the activating engrailed (En) genes 
which are required for proliferation and survival of the ventral midbrain 
cells. 
 
1.3. Specification and differentiation of midbrain dopamine 
neurons 
 
The generation of mDA neurons from a neural progenitor can be 
divided into three distinct steps: the regional specification (1) described 
above and involving the specification of midbrain cells, the early (2) 
and late (3) differentiation (Ang, 2006). 
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Each step is caracterized by a combinatorial expression of 
transcription factors. 
During the regional specification, factors such as the bicoid class 
homeodomain transcription factor (TF) Otx2, LIM homeodomain TFs 
Lmx1a/b are expressed in neural stem cells and mitotic precursors and 
serve as a marker for these cells (Ang, 2006). 
Otx2 is expressed in midbrain and forebrain between E8.5-E12.5 and 
is required for restricting posterior brain development, for positioning 
the expression of Wnt1 and Fgf8 at the MHB (Brodski et al., 2003), 
and for limiting the dorsal extent of Shh expression in the ventral 
midbrain (Puelles et al., 2003). Otx2 represses Nkx2.2, a major 
repressor of mDA neuron development (Puelles et al., 2004). 
 Moreover, Otx2 regulates the expression of a proneural genes such 
as Neurogenin2 (Ngn2) an important proneural factor for mDA neuron 
generation (Kele et al., 2006) as shown by Otx2 conditional 
inactivation (Vernay et al., 2005). 
Lmx1a and Lmx1b play important roles in the developing brain. Their 
expression is required for the specification and maintenance of mDA 
neuron (Yan et al., 20011)  
Other transcription factors which promote the specification of mDA 
neuron are the forkhead/winged helix transcription factors Foxa1 and 
Foxa2. Foxa1 and Foxa2 function cooperatively to regulate mDA 
progenitor specification by regulation the expression of key regulatory 
genes such as Lmx1a, Lmx1b and Ngn2 (Ferri et al., 2007). In addition 
Foxa2 positively regulate the expression of floor plate-specific genes 
while negatively regulating the expression of ventrolateral-specific 
genes in mDA progenitors to specify mDA neurons and floor plate 
identity ( Lin et al., 2009; Metzakopian et al., 2012)  
Engrailed homeodomains proteins are required for the generation and 
survival of mDA neurons (Simon et al., 2011). 
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Nurr1 is an early differentiation marker which controls the 
dopaminergic neuron transmitter phenotype. Nurr1 regulates the 
expression of several genes that are required for dopamine synthesis 
and homeostasis, such as tyrosine hydroxylase (TH), vesicular 
monoamine transporter 2 (VMAT2), dopamine transporter (DAT) and 
RET receptor tyrosine kinase. (Filippi et al., 2007; Baron et al., 2012). 
 
 
 
 
 
 
 
 
Figure 4. Midbrain dopamine neurons during three distinct steps of 
differentiation. Cross section of ventral midbrain of an E12.5 embryo. the right panel 
is an enlarged view of ventral midbrain. Ventral midbrain progenitors start to migrate 
from the ventricular zone (1) towards the intermediate zone (2) around E 9.0 and once 
they reach the marginal zone (3) they become postmitotic neurons. 
 
Another transcription factor implicated in the regulation of TH and the 
proper differentiation of a subset of mDA neurons is the paired-like 
homeodomain protein Pitx3. Pitx3 is a mature neuron marker and is 
expressed in both the SNpc and VTA. However lack of Pitx3 results in 
the preferential loss of the SNpc neuronal sub-population whereas 
VTA are relatively non-affected (Nunes et al., 2003). 
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1.4 LIM homeodomain transcription factors and their crucial 
role in the specification and maintenance of midbrain 
dopamine neurons. 
 
Lmx1a and Lmx1b belong to the family of of LIM homeodomain 
transcription factors and share 64% homology in their overall 
amminoacid composition. The homeodomain, which bind DNA in a 
sequence-specific manner, is an evolutionary conserved 60 amino acid 
sequence. It was first identified in a number of Drosophila homeotic 
proteins and segmentation proteins. The domain binds DNA through a 
helix-turn-helix (HTH). The HTH motif is characterised by two alpha-
helices, which make intimate contacts with the DNA and are joined by 
a short turn.  
Lmx1b is expressed in the midbrain from E8.0 onwards (Smidt et al., 
2000), but this expression becomes restricted by E9.5 to the roof plate, 
mid-hindbrain boundary and the ventral midbrain. Loss-of-function 
studies have shown that Lmx1b is required for the maintenance of TH 
positive (TH+) neurons. TH+ neurons are found in Lmx1b-/- mutants up 
to E16.0, even though they fail to express Pitx3 (Smidt et al., 2000). 
This differentiation defect results in the eventual loss of mDA neurons 
in Lmx1b-/- embryos. Being that Lmx1b is initially broadly expressed in 
midbrain it is still unknown if the mDA phenotype of Lmx1b mutant is 
due to an intrinsic role of Lmx1b in the mDA lineage or to earlier 
patterning functions in the midbrain. 
Lmx1a expression begins at E9.5 in the ventral midbrain and 
progressively expands dorsally (Andersson et al., 2006). Lmx1a 
function during brain development was first analysed in the 
spontaneous mouse mutant dreher (Falconer & Sierts-Roth, 1951; 
Millonig et al., 2000). The point mutation in Lmx1a in dreher mice 
results in the loss of roof plate. Dreher mutants (Lmx1adr/dr) exhibit a 
complex phenotype including circling behaviour, sterility, pigmentation, 
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and tail abnormalities, and loss of 46% of TH+ neurons, (Lyons and 
Whalsten., 1988, Chizhikov et al., 2006). Lmx1a is a very potent factor 
for promoting mDA neurons generation and it acts as an intrinsic 
determinant in promoting mDA neurons fate development (Andersson 
et al., 2006). Known to act as a transcriptional activator, Lmx1a further 
induces msh homeobox1 (Msx1), which together with Lmx1a promotes 
neuronal differentiation and suppresses alternative ventral cell fates. 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Lmx1a role in mDA neuron specification. Shh promotes the expression of 
Lmx1a and probably of other transcription factors in ventral midbrain cells. Lmx1a 
works together with these unknown transcription factors to specify immature mDA 
neurons. Lmx1a acts as a transcriptional activator and turns on Msx1 expression , 
which has as a downstream target Ngn2. Ngn2 expression stimulate neuronal 
differentiation and subtype specification of immature dopamine neurons. Msx1 acts as 
a transcription repressor by inhibiting Nkx6.1 expression (Ang, 2006). 
 
Overexpression of Lmx1a in the ventral midbrain of chick embryos led 
to robust generation of mDA neurons. It is important to note Lmx1a 
function is context dependent. Lmx1a can indeed induce dopamine 
neurons in ventral midbrain, but not dorsally. This suggests that Lmx1a 
alone is not sufficient to induce mDA neurons and that other factors 
are required. 
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Although these studies has identified Lmx1a as a crucial TF for mDA 
neurons generation, only 46% of mDA neurons are lost in the 
Lmx1adr/dr mutant mouse embryos suggesting that the related family 
member Lmx1b may compensate for Lmx1a function (Ono et al., 
2007). Severe loss of mDA neurons occurred in Lmx1a and Lmx1b 
double mutants (Lmx1adr/dr; ShhCre/+ ; Lmx1bf/f) (Yan et al., 2011). 
 Lmx1a and Lmx1b cooperate to regulate proliferation of mDA 
progenitors and specification of postmitotic mDA neurons. 
Mature mDA neurons continue to express Lmx1a suggesting that it 
has a role in regulating other genes implicated in the midbrain 
dopaminergic neurotransmitter phenotype (Chung et al., 2009, Chung 
et al., 2012). 
Given his ability to generate mDA neurons when it is ectopically 
expressed, Lmx1a overexpression has been recently used as a potent 
tool in many in vitro differentiations assays to induce an efficient 
production of mDA neurons (Andersson et al., 2006; Cai et al., 2009; 
Friling et al., 2010). 
All these studies support Lmx1a as a crucial determinant for mDA 
neurons development, but its role during mDA neurons specification 
and maturation needs to be further analysed. 
 
1.5 Parkinson’s disease and the implication of midbrain 
dopamine neurons 
 
Parkinson’s disease is a chronic progressive neurodegenerative 
movement disorder characterized by a profound and selective loss of 
dopamine nigrostriatal neurons. It affects several regions of the brain, 
including the pigmented nuclei in midbrain and brainstem, the olfactory 
tubercle, the cerebral cortex and elements of the peripheral nervous 
system (Braak et al., 2006). The symptoms of Parkinson’s disease are 
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called “parkinsonisms” and include paucity, slowness of movement 
(akinesia and bradykinesia), muscle stiffness (rigidity), tremor at rest 
and postural instability. Parkinson’s Disease affects approximately 1% 
of the global population over 50 years of age. In large parts the 
problems result from the degeneration of midbrain dopamine neurons 
and the subsequent disruption of the normal circuits between the basal 
ganglia and the cortex (Galvan & Wichman, 2008). The basal ganglia 
include the neostriatum (caudate nucleus and putamen), the external 
and internal pallidal segments (GPe, GPi), the subthalamic nucleus 
(STN) and the substantia nigra pars reticulata (SNpr) and pars 
compacta (SNpc). The medium spiny output neurons (MSNs) of 
striatum receive glutamatargic inputs from specific areas of the cortex 
and transfer the information to the basal ganglia output nuclei, Gpi and 
SNpr. The information from these neurons can be transferred to the 
output nuclei by two distinct pathways, the direct and indirect pathway. 
In the indirect pathway the striatal neurons transfer the information to 
the GPi/SNpr via the intercalated GPe and STN. Output from Gpi/SNpr 
goes to innervate the ventral anterior and ventrolateral nuclei of the 
thalamus (VA/VL), which in turn project back to the cortex. The MSNs 
also receive prominent dopaminergic input, from the midbrain 
dopamine neurons of SNpc, which projections terminate predominately 
at the necks of their dendritic spines.  
There are two types of dopamine receptors expressed in the striatum –
the D1 and D2 receptors. D1 receptors are expressed in neurons of 
the direct pathway, whereas D2 receptors are expressed in neurons of 
the indirect pathway (Gerfen et al., 1990). These pathways are thought 
to have opposite functions. The direct pathway leads to the inhibition of 
Gpi and SNr thereby enhancing the activity of neurons in cortex and 
the thalamus leading to a better control of voluntary movement. In 
contrast, the indirect pathway activates Gpi and SNr activity, which 
inhibit the cortico-thalamic and brainstem neurons and that leads to a 
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reduced movement (Galvan & Wichmann, 2008; Wichman et al., 2011. 
Depending on the receptor that is expressed, dopamine can act either 
as a stimulatory neurotransmitter (D1 receptors) or as an inhibitory 
neurotransmitter (D2 receptor). Therefore, dopamine transmission acts 
stimulatory on the direct pathway and inhibitory on the indirect 
pathway, thus facilitating movement. 
Until today what causes the degeneration of SNpc neurons is not 
clear. To date, Parkinson’s disease is considered to be a prion-like 
disease as the accumulation of Lewy bodies occurs in the SNpc 
neurons, which might mediate neurodegeneration (Olanov & Brundin, 
2013). Lewy bodies are aggregates of α−synuclein. An increase in the 
dose of SNCA gene, encoding α−synuclein causes fully penetrant 
Parkinson’s Disease. Defects in other genes such as Parkin, LRRK2, 
PINK1, DJ-1 are also associated with Parkinson’s Disease (Thomas 
&Beal, 2007) 
Although a small proportion of patients (less than 10% of all cases) 
have a direct inherited mutation, multiple genetic predispositions and 
environmental factors are commonly involved. However the pathways 
underlying Parkinson’s disease are highly complex and further 
research remains to be done to fully understand it’s driving causes 
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Normal Parkinsonism 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. Schematic representation of the neuronal motor circuit between basal 
ganglia and cortex in a normal state and Parkinson’s disease. Grey arrows are 
excitatory, black arrows inhibitory. Thickness of arrows indicates their activity. In 
Parkinson’s the neuronal circuit between the basal ganglia and the thalamo-cortical 
neurons is impaired. This is owed to a reduced dopamine transmission, due to the 
degeneration of SNpc neurons which project to the striatum. This leads to activation of 
the indirect pathway and subsequently to the activation of the output nuclei and thus to 
symptoms of Parkinsons, such as hypokinesia. 
Abbreviations: CM, centromedian nucleus of thalamus; CMA, cingulate motor area; 
Dir., direct pathway;D1 and D2, dopamine receptor subtypes; Gpe, external segment 
of the globus pallidus; Gpi, internal segment of the globus pallidus ; Indir, indirect 
pathway; M1, primary motor cortex; Pf, parafasicular nucleus oh thalamus; PMC, 
premotor cortex; PPN, pedunculopontine nucleus; SMA, supplementary motor area; 
SNc, substantia nigra pars compacta; SNr, substantia nigra pars reticulate; STN, 
subthalamic nucleus; VA, ventral anterior nucleus of thalamus; ventrolateral nucleus of 
thalamus 
 
1.6 Managing Parkinson disease 
 
More than a dozen of drugs have been approved by the US Food and 
Drug Administration (FDA) for treating Parkinson’s disease. 
All current drugs activate dopamine neurotransmission in the brain. 
Most, if not all, currently available drugs for Parkinson’s disease 
address dopaminergic loss and relieve symptoms. The major problem 
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of all of them is that after 4 to 6 years of treatment their effect wears-off 
and some of them have disabling side effects on patients such as, 
dementia and mood disturbances. Therefore there is a strong need for 
alternative therapeutic options, such as  cell replacement therapy, 
which could be the ultimate cure Parkinson’s Disease by replacing the 
degenerated mDA neurons.  
It has been shown that implantation of fetal mesencephalic tissue 
showed clinical benefit in a subset of patients. However, the outcome 
was highly dependent on the amount of denervated neurons. 
Moreover, a significant side effect, which has not been observed in 
prior animal studies, was graft-induced dyskinesia (GID) (reviewed by 
Lindvall & Bjorklund, 2011). Due to these problems and ethical issues 
this therapy is not established as an ultimate treatment option. The 
current research area is in vitro generated stem cells. They could 
provide an infinite source of dopamine neuron precursors for cell 
replacement therapies. Some studies have shown that overexpressing 
Lmx1a during mouse embryonic stem cell (mESC) differentiation or 
human embryonic stem cell (hESC) differentiation in vitro leads to high 
yields of mDA neurons (Anderson et al., 2006; Cai et al., 2009; Friling 
et al., 2009; Chung et al,. 2009) . 
However the molecular network downstream Lmx1a remains unclear. 
We generated an ESC line which conditionally overexpress Lmx1a 
under the control of tetracycline response elements (TRE). We 
generated this cell line to look at the immediate targets of Lmx1a and 
to determine when is the Lmx1a expression required during 
differentiation to lead to efficient production of midbrain dopamine 
neurons. 
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1.7 Aims of my thesis 
 
The aims of my work were to identify the genes which are regulated by 
Lmx1a using an epiblast differentiation essay and to generate an in 
vitro model system which we could use to validate the .RNAseq list 
from Lmx1a/Lmx1b double mutants midbrain (Ang’s lab, data non 
shown). 	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2. Experimental procedures 
 
2.1 Cell culture  
 
2.1.1 Cell Culture of embryonic stem (ES) cells 
 
Mouse embryonic stem cells (TKTA2, Nes-Lmx1a, E14TG2A) were 
cultured E14 media which contains Dulbecco’s modified Eagle Medium 
(DMEM) (Invitrogen), supplemented with 16% Fetal Bovine Serum 
(FBS), 1% Non-essential amino acids (Invitrogen), 1% Sodium 
Pyruvate (Invitrogen), 1% Glutamine, 1% Penicllin/Streptomycine 
(Sigma), 2000 U/ml Leukemia inhibiting factor (LIF) (Chemicon) and 
0.0006% 2-Mercapthoethanol. 
Cells were cultured on gelatinised plates at 37°C and 5% CO2 and 
splitted at a confluency of about 80%. 
 
2.1.2 Differentiation of ES cells into epiblast stem cells 
(EpiSCs) 
 
For in vitro differentiation of ES cells into epiblast stem cells (EpiSCs), 
ES cells were cultured on gelatinised 6-well plates, scraped from the 
well and passaged to FBS coated 6 well plates at three different 
densities (300 µL/well, 150 µL/well and 75 µL/well). Epiblast SCs were 
cultured in N2B27 differentiation media (Ying et al., 2003) containing 
25 µg/mL Activin (R&D Systems) and 10 µg/mL Fgf2 (Peprotech) to 
maintain Epiblast SC stage. The cells were passaged once they reach 
80 % confluency (or before they start to grow in 3D structures). 
Mouse EpiSCs were established from TKTA2-pZeo TRE, TKTA2-pZeo 
TRE Lmx1a, Nes-Lmx1a, E14TG2A mouse ESC. 
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2.1.3 Differentiation of EpiSC into midbrain dopamine 
neurons  
 
To differentiate the Epiblast SCs into midbrain dopamine neurons, the 
EpiSC were passaged at a confluency of 80% to 24 and 6 well plates 
previously coated with 0.01% poly-L-lysine (Sigma) and 10ng/ml 
Laminin (Sigma) for 2 hours successively. Cells were plated at a 
density of of 60 µL/well or 300 µL/well and cultivated in N2B27. 
PD0325901 (Axon Medchem) was added for 2 days at a final 
concentration of 1 µM/ml of N2B27. At D2 PD treatment was stopped 
and the cells were kept only in N2B27 media. From d5-d9 the cells 
were cultured in N2B27 containing 100ng/ml Fgf8 and 100 ng/ml of 
Sonic Hedgehog Agonist (SAG). At d9 10 ng/ml of GDNF, BDNF and 
Ascorbic acid (Peprotech) were added as growth factors and they were 
maintained till d14. 
 
2.2 Electroporation of DNA constructs into TKTA2 ES cell 
line 
 
For electroporation of the pZeoTRELmx1a and pZeoTRE constructs 
into TKTA2 ES cell line, vector was linearized with ScaI (1U/µL). ES 
cells were refeeded 3 hours prior to electroporation and trypsinated. 
Approximately 107 cells were spinned down and washed with PBS. 
Cells were resuspended in DMEM to which 100 µL of 50 µg/mL of 
DNA in DMEM was added to 900 µL cell suspension. Cells were 
transferred into cuvettes and incubated for 10 min on ice before before 
electroporation. Cells were electroporated twice with a capacitance of 
500 uF and 240V for the first shock and 230V for the second shock, for 
6ms for both shocks Afterwards cells were incubated on ice for 20 
minutes and grown in E14 media. The Zeocin selection was started 
after 24h after electroporation and was kept for a week after 
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electroporation at a concentration of 100ng/ml. At d8 the clones that 
were Zeocin resistant were picked up, expanded and subsequently 
screened for the construct integration. 
 
2.3 Southern Blot 
 
2.3.1 Preparing sample DNA from ES cells 
 
Cells were lysed with 0.5mg/ml Proteinase K at 37°C o/n, precipitated 
in 1.9 M NaCl and 2 volumes of 100% EtOH and resuspended in 50 µL 
H2O. DNA was digested with Hind III) (1 U/µL) (Roche) at 37 ̊C o/n. 
Digested DNA were separated on a 0.9% agarose gel. DNA was 
depurinated in 0.8% HCl, then denatured in 1.5 M NaCl and 0.5 M 
NaOH for 30 minutes each. After neutralizing with 1mM and 1.5 M 
NaCl, DNA was transferred onto a N-Hybond membrane (Amersham, 
GE Healthcare) over night using capillary forces (Southern, 2006). 
After UV-crosslinking the DNA to the membrane, it was pre-
hybridiesed in Prehyb-buffer (Southern, 2006). 
 
2.3.2 Preapring of DNA probes 
 
pZeo TRE and pZeo TRELmx1a constructs were digested with (U/µL) 
() and a bp fragment containing the Lmx1a and Zeocin gene purified. 
32P-labelled DNA probes were made against Zeocin using the Prime-IT 
RmT Random Primer Labeling Kit (Stratagene) according to 
manufactures’s instructions. Probes were added to prehybridisation 
buffer and incubated at 60 o/n. Membranes were washed two times for 
30 minutes with 1X SSC, 0.1% SDS and with 0.1X SSC, 0.1% SDS. 
Radiation signal was detected by exposing an autoradiography 
(Hypersham) at -80°C. 
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2.4 Immunocytochemistry  
 
Cells were plated in 24 well plates with coverslip at a density of 20.000 
cells/well. They were fixed with 4% Paraformaldehyde (PFA) for 10 
minutes at room temperature (RT) and washed with 1X PBS. Cells 
were permeabilised with 0.25% Triton-X for 10 min at RT , washed 
with 1X PBS and blocked with 3.5%bovine serum albumin (BSA) for 30 
minutes. Primary antibody was added over night diluted in 3.5% BSA. 
Primary antibodies used were goat anti Sox2 (Immune systems Ltd) 
(1:500), mouse anti β-tubulin (Covance) (1:1000), rabbit anti Foxa2 
(1:1000), rabbit anti Lmx1a (gift from M.German (1:1000), rabbit anti 
Otx2 (1:1000), rabbit anti TH (Pel-Freez Biologicals) (1:1000), rat anti 
Nestin (1:500). Cells were incubated with appropriate secondary 
antibodies for 1h at RT diluted 1:300 in 3.5% of BSA ( Jackson 
Laboratories and Life Technologies). 
 
2.5 Real time qPCR 
 
2.5.1 RNA isolation and cDNA synthesis 
 
RNA extraction from cell lysates was performed using the Arcturus® 
PicoPure® RNA Isolation Kit (Applied Biosystems) according to 
manufacturer’s instructions. A cDNA library was created using the 
SuperScript III (Invitrogen) following manufacturer’s protocol. 
 
2.5.2 RT-qPCR analysis 
 
To quantify the expression levels of mRNA, real-time PCR was carried 
out using Platinum SYBR Green Super mix (Invitrogen) and the 7900 
PCR System (ABI). Each experiment included biological triplicates. 2 
µL of 1:50 cDNA dilution was amplified in 
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 20 µL with 0.5X Sybr Green (Invitrogen) and 0.5 µM primer with 45 
cycles (95 ̊C for 30 seconds, 60 ̊C for 30 seconds, 72 ̊C for 30 seconds 
and 79 ̊C for 5 seconds). Fluorescence signals were detected at 79 ̊C 
at each cycle (ct-value) and normalized to the glycerine aldehyde 
phosphate dehydrogenase (GAPDH) control (2CtGAPDH-Ctgene). The 
dissociation curve of each PCR product was determined to ensure that 
the observed fluorescent signals were only from specific PCR 
products. Primers used are listed in table 1. 
 
 
 
 
 
 
 
 
 
 
 
 
Table1: Primer used for RT-PCR. 
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3.Results 
 
3.1 In vitro characterisation of Lmx1a gain-of-function 
 
3.1.1 Generation of Lmx1a conditional overexpression cell 
line 
 
To examine the effect of Lmx1a on specification and differentiation of 
mDA neurons, I generated ES cell lines overexpressing Lmx1a upon 
doxycycline treatment. A vector containing tetracycline responsive 
element (TRE) upstream the Lmx1a gene (TRE-Lmx1a) was 
electroporated in ES cells (TKTA2), which harbour the reverse 
tetracycline transactivator (rtTA) in the Rosa26 locus. Therefore Tet-
ON system (reviewed by Gossen et al., 1995) allows the controlled 
overexpression of Lmx1a. We also generated control ES cell lines 
transfected with the empty vector (pZeoTRE). Zeocin resistant clones 
were selected and checked by Southern Blot for single copy insertion 
(Fig.7A, B). The size of the inserted vector cannot be predicted due to 
a random insertion of the construct but it is expected to be over 4.4 kb 
for the pZeo TRE and over 5.6kb for the pZeo TRE Lmx1a.  
For the pZeoTRE construct all of four analysed clones harbour a single 
copy insertion (A1 clone was used as control clone for the rest of the 
experiments). Regarding the pZeoTRE-Lmx1a construct, only 3 out of 
5 selected clones presented single copy insertions. Multiple copy 
insertion (clone C2) as well as false positive (clone C4) can be 
identified by Southern Blot (Fig. 6B). Clone C5 was used for further 
analysis. 
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Figure 6.Generation of control and Lmx1a gain-of-function cell lines.  
A) Linearised vector, containing TRE and Zeocin was electroporated in TKTA2 ES 
cells to generate control cell lines. pZeo TRE vector containing the Lmx1a coding 
sequence was electroporated into TKTA2 ES cells to generate Lmx1a gain of function 
cell lines. B) Genomic DNA was digested with HindIII to check for single copy 
insertions. HindIII cuts in the vector sequence (red line) and in the genome of TKTA2 
cells (blue line). Clones A1-A5 (electroporated with pZeo TRE) and C2-C6 clones 
(electroporated with pZeo TRE Lmx1a) were checked for single copy insertion by 
Southern Blot using 32P-labelled probes against Zeocin. DNA ladder is on the left side 
(L). C is the control DNA for the Zeocin probe. 
 
3.1.2 Efficient overexpression of Lmx1a upon doxycycline 
stimulation 
 
Previous study showed that treatment with 100 ng/ml doxycycline is 
sufficient to induce the expression of the desired gene in TKTA2 cells 
(Gennet et al., 2011). We decided to start our experiments with 100 
ng/ml (low dose) and 1000 ng/ml (high dose) for 24h. Lmx1a 
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expression has been checked by real time quantitative PCR (RT-
qPCR) and immunofluorescence. mRNA level showed that Lmx1a 
induction doesn’t seem to be dose dependent as higher doses doesn’t 
lead to higher expression levels of Lmx1a. On the contrary, the high 
dose treatment leads to lower expression of Lmx1a suggesting a 
potential toxicity of high doxycycline dose. Consequently, we use the 
low dose for the rest of the experiments (100 ng/ml). 
Lmx1a protein is clearly identifiable in C5 clone after 24 h with 
doxycycline treatment. No Lmx1a is detectable on either control cells 
or untreated C5 cells. 
Doxycycline treated C5 clone present a highly significant Lmx1a 
induction compared to untreated cells (> 100 folds). The A1 control cell 
line shows significantly lower levels than untreated C5 clone 
suggesting a low leakage of the Lmx1a expressing vector. 
These results demonstrate that C5 is able to express Lmx1a upon 
doxycycline treatment in ES cells and that C5 untreated clone can be 
used together with A1 clone as a control for the experiments. 
 
 
 
 
 
 
 
 
 
Figure 8. Efficient expression of Lmx1a in ES cells upon doxycycline 
stimualation. A) Lmx1a transcriptional level was determined by qPCR for clone C5. 
Significant leakage of the construct was observed in ES cells. Values are presented as 
mean ± SEM (***p<0.001). B) Immunostaining reflecting Lmx1a and Sox2 expression 
in ES cells. By immunostaining Lmx1a isn’t detectable in A1 and in the untreated with 
Doxycycline C5 clone. 
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3.1.3 Differentiation of ES cells to midbrain dopamine 
progenitors 
 
As Lmx1a is known regulator of dopamine neuron specification and 
differentiation, we asked how it can influences these processes when 
overexpressed at different time points of in vitro differentiation. This 
system can also be a powerful tool to validate differentially expressed 
genes obtained by RNA-seq analysis. For the analysis of Lmx1a gain-
of-function, we made use of a published in vitro differentiation 
published in 2011 (Jaeger et al., 2011). This protocol is based on a 
temporary inhibition of the FGF pathway upon differentiation of epiblast 
stem cells (EpiSCs) to mDA neurons to suppress forebrain identity and 
promoting midbrain cell fate. 
In order to facilitate a synchronous differentiation to mDA neurons, we 
first differentiated ES cells towards EpiSCs as these show a more 
homogenous differentiation program compared to ES cells (Jaeger et 
al., 2011). In order to use the C5 clone for the experiments we first 
verified if the EpiSCs retain the capacity to induce Lmx1a upon 
doxycycline treatment. In EpiSC, RT-qPCR analysis show that the 
transcriptional levels of Lmx1a are 10 times higher in treated versus 
untreated cells. 
In order to check Lmx1a levels during differentiation, we induced its 
expression from day 2 (d2) and analyse its expression at d3, d4 and 
d5 by immunofluorescence and RTqPCR (Fig. 9).  
Even though induction is clearly detectable by RT-qPCR (10 fold 
induction at d3), no difference in Lmx1a immunoreactivity at d3, d4 and 
d5. The number of Lmx1a-positive cells is comparable in treated and 
untreated C5 clone. This clone is therefore unsuitable for the analysis 
of Lmx1a gain-of-function. We therefore decided to use another cell 
line: NesE-Lmx1a (Andersson et al., 2006) 
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Figure 9 Lmx1a is not expressed in C5 EpiSC monolayer differentiation(MD)g 
cultures. (A) Lmx1a transcript levels on d3 C5 EpiSC. Values are presented as mean 
± SEM (** p<0.01, relative to C5 –PD EpiSC non treated with doxycycline at d2). (B) 
Lmx1a kinetics expression in C5 EpiSC MD cultures from d3 to d5. Cells were treated 
with doxycycline at d2 and checked for Lmx1a expression at by immunocytochemistry 
d3, d4, d5. 
 
3.2. Gain of function studies using a cell line which 
expresses Lmx1a under the control of Nestin enhancer. 
 
3.2.1 Nestin is expressed in neural progenitor cells (d3-d9) 
 
NesE-Lmx1a cell line was first described by Andersson and colleagues 
(Andersson et al., 2006). This transgenic cell line was obtained by 
transfecting wild type E14Tg2a ES cells (E14) with a vector containing 
Lmx1a coding sequence under the control of Nestin enhancer. Nestin 
is an intermediate filament protein that is known to be expressed in 
neural progenitor cells. In NesE-Lmx1a cell line, Lmx1a will be 
expressed when Nestin enhancer is active. We used this cell line to 
dissect Lmx1a role during mDA neuron specification when it’s 
expressed at neural progenitor stage. In order to use this cell line we 
performed immunostaining for Nestin to check when Nestin enhancer 
is active during in vitro differentiation. As a control cell line we used the 
E14 cells that I differentiated into EpiSC. For the experiments I used 
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two different conditions: with or without PD0325901 (subsequently 
referred as +PD or -PD). In the +PD condition, cells are treated with 
PD0325901, an FGF antagonist for the first two days of differentiation. 
On the other hand, -PD, cells are kept in N2B27 media. By 
immunostaining I could see that Nestin expression starts at d3 of 
differentiation, reaches a maximum around d5 and decrease from d7 
to almost complete abolishment at d9 where only some cells express it 
(Fig. 10A). These results show that Nestin enhancer is on from d3 to 
d7 of in vitro differentiation. In order to check if PD treatment increases 
neurogenesis, we analysed day 5 Nestin expression by RT-qPCR in 
NesE-Lmx1a and control E14 cells. I couldn’t detect any significant 
difference between the two conditions (+ or -PD) for each cell line 
suggesting that PD treatment doesn’t have any effect in inducing 
neurogenesis in our protocol (Fig. 10B). We also couldn’t detect any 
difference between E14 and NesE-Lmx1a cells when treated with the 
same conditions suggesting that Lmx1a overexpression in neural 
progenitor doesn’t lead to an enhanced neurogenesis (Fig10B). 
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Figure 10. Analysis of Nestin expression at different time points of 
differentiation. (A) E14Tg2a and NesE-Lmx1a EpiSC immunostained for Nestin 
(green) at d3, d5, d7, d9 of differentiation. (blue) DAPI nuclear labelling. (B) RT-qPCR 
analysis of Nestin expression at d5 MD cultures of E14 Tg2a and NesE-Lmx1a EpiSC. 
Values are presented as relative transcript levels ± SEM (ns-statistically non significant 
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3.2.2 Lmx1a is overexpressed in NesE-Lmx1a neural progenitors 
 
Being under the control of Nestin enhancer in NesE-Lmx1a cells, 
Lmx1a should be expressed in neural progenitors deriving from this 
cell line. It has been previously shown that FGF/ERK signalling 
blockade (+PD) of E14 cells induces elevated levels of Lmx1a 
transcript compared to -PD culture (Jaeger et al., 2011 and Fig. 10). 
We hypothesized that +PD NesE-Lmx1a cells should express higher 
levels of Lmx1a transcript compared to other conditions 
(overexpression due to both NesE-Lmx1a transgene and PD 
treatment).  
Consistent with Nestin expression (Fig. 10) already detectable at d3, a 
higher proportion of NesE-Lmx1a neural progenitors express Lmx1a 
compared to E14 neural progenitor cells. We cannot detect any 
increase of Lmx1a expression upon PD treatment for NesE-Lmx1a 
progenitors whereas E14 cells behave as previously published (Jaeger 
et al., 2011 and Fig. 11). Both protein and transcript level concur to an 
overexpression of Lmx1a in NesE-Lmx1a compared to E14 but no 
difference between + or -PD. 
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Figure11. Analysis of Lmx1a expression at d5 of differentiation. (A) 
immunodetection of Lmx1a (red) on E14 and NesE-Lmx1a d5 MD cells (B) RT-qPCR 
analysis of Lmx1a expression at d5 MD cultures of E14 and NesE-Lmx1a cells. Values 
are presented as relative transcript levels ± SEM (* p<0.05, ** p<0.01, *** p<0.001) 
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3.2.3 Lmx1a overexpression positively regulates midbrain 
dopamine neuronal markers and midbrain floor plate genes 
 
The effect of Lmx1a overexpression in neuronal specification was 
determined by analyzing the expression levels of mDA neuronal 
progenitor markers as well as midbrain floor plate genes. 
It has been shown that Lmx1a induces the expression of Msx1, which 
then induces the proneural gene Ngn2 and subsequent neuronal 
differentiation (Andersson et al., 2006). It seems that overexpression of 
Lmx1a from d3 enhances the expression of Ngn2 at d5 (Fig.12A). 
Foxa2 is an important marker for mDA neuronal progenitors and RNA 
analysis show that although wild type cells treated with PD show 
higher levels of Foxa2 at d5, no difference is found in Foxa2 mRNA 
levels with or without PD treatment for NesE-Lmx1a cells. However, 
NesE-Lmx1a cells still show higher levels of Foxa2 compared to wild 
type neural progenitors (Fig. 12B). 
We also checked the expression levels of Nurr1, a known postmitotic 
marker for mDA neuron. Nurr1 expression at d5 is significantly higher 
in neural progenitors deriving from Nes-Lmx1a cells -PD compared to 
wild type cells. Nurr1 upregulation at d5 consistent with Lmx1a 
overexpression suggests that Lmx1a could act as an intrinsic 
determinant for mDA neurons by regulating Nurr1 expression (Fig 
12C).  
Based on the above results we wanted to know if the upregulation of 
these genes is due to the fact that cells which overexpress Lmx1a from 
d3, at d5 are committed versus a dopaminergic fate and at d5 we have 
more mDA progenitors or Lmx1a somehow regulates the expression of 
these genes. Otx2, together with Lmx1a and Foxa2, is used as a 
marker for mDA progenitors. We carried out RT-qPCR to see if there is 
any change in the transcriptional levels of Otx2 at d5 between E14 and 
NesE-Lmx1a neural progenitors (Fig. 12D). No significant difference 
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was detected suggesting that Lmx1a does regulates these genes and 
the increase in mRNA levels for these genes is owed to Lmx1a 
overexpression and not to an increase in the number of dopamine 
neuronal progenitors. According to what has been previously published 
(Andersson et al., 2006), the upregulation of Nurr1 at d5 suggests us 
that Lmx1a acts as an intrinsic determinant for mDN by regulating 
genes that are important for mDA neurons specification and 
differentiation. 
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Figure 12. Lmx1a positively regulates Ngn2, Foxa2, Nurr1 but not Otx2. (A, B) 
Expression of mDA neuron progenitor markers Ngn2 and Foxa2 is upreguated in 
NesE-Lmx1a cells compared to E14 cells treated with the same conditions. (C) Nurr1 
is upregulated in NesE-Lmx1a cells at d5 MD cultures (D) Lmx1a expression from d3 
in NesE-Lmx1a cells doesn’t increase the number of mDA neural progenitors. Values 
are presented as relative transcript levels ± SEM (ns-non significant, * p<0.05, ** 
p<0.01, *** p<0.001, Student’s t-test). 
 
Next we examined the expression of floor plate markers such as 
BMP7, Arx1, Lmx1b and Slit2. Apart from Lmx1b, all the other genes 
are significantly upregulated (Fig 13). 
Slit2 is an axon guidance molecule that has previously shown to 
regulate, in vivo, the position of ascending dopaminergic fibers 
projecting into the forebrain (Bagri et al., 2002, Dugan et al., 2011). 
Consistent with previously published data (Yan et al., 2011), we show 
that, in vitro, Lmx1a positively regulates Slit2. Recent studies from the 
lab showed that Lmx1a is not required for Arx expression (Yan et al. 
2011). However, we show here that in vitro Lmx1a overexpression 
positively regulates Arx. 
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Figure 12. Lmx1a positively regulates the expression of midbrain floor plate 
genes. NesE-Lmx1a and E14 cells were differentiated in absence of PD and analyzed 
for ARX, BMP7, Lmx1b and Slit2 at d5 MD. Values are presented as mean ± SEM of 
three biological replicates of the same experiment (ns-non significant, * p<0.05, 
relative to no PD controls (Student’s t-test). 
 
3.2.4 Lmx1a continue to be overexpressed at d9 of 
differentiation 
 
By immunocytochemistry we couldn’t detect Nestin at d9 of 
differentiation which means that at d9 Nestin enhancer isn’t active 
anymore. However, Lmx1a seems to be still overexpressed at d9 of 
differentiation in NesE-Lmx1a cells compared to wild-type cells 
(Fig.14). 
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Figure 14. Lmx1a is upregulated in NesE-Lmx1a at d9 MD cultures. RT-qPCR 
analysis show that Lmx1a is upregulated in NesE-Lmx1a compared with WT cells. 
Values are presented as mean ± SEM (ns-statistically non significant, ** p<0.01, *** 
p<0.001, Students t-test). 
 
We also checked the transcriptional levels of two postmitotic neuronal 
markers, Tuj1 and Nurr1 at d9. qPCR results show that these genes 
are upregulated in NesE-Lmx1a neural cells compared to wild type 
cells (Fig.15). Upregulation of these genes in NesE-Lmx1a suggests 
us Lmx1a overexpression positively regulates these genes and 
therefore promotes cell cycle exit and differentiation. 
We did not observe an increase in the mRNA levels of Th at d9 in Nes-
Lmx1a cells compared to wild type cells (Fig.16). 
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Figure 15. Tuj1 and Nurr1 are upregulated in NesE-Lmx1a cells at d9 MD. (A, B) 
Comparison of transcriptional levels of Nurr1 and Tuj1 in NesE-Lmx1a and E14 cells in 
d9 MD cultures with or without PD. Values are presented as mean ± SEM of three 
biological replicates of the same experiment (** p<0.01, *** p<0.001). 
 
 
 
 
 
 
 
 
 
Figure 16. Lmx1a upregulation at d9 NesE-Lmx1a mDA neuron progenitors d3-
d9 doesn’t lead to an enhanced TH expression at d9. qPCR analysis showing no 
significant difference in TH transcriptional levels between NesE-Lmx1a and E14 Tg2a  
with or without PD at d9 MD cultures.Values are presented as mean ± SEM of three 
biological replicates of the same experiment (ns-statistically non significant) 
 
____________________________________________________________RESULTS 
 35 
3.2.5 Validation of some genes from RNA Seq list 
 
Previous work in the lab showed that Lmx1a and Lmx1b function 
cooperatively to regulate proliferation, specification and differentiation 
of midbrain dopamine progenitors by using Lmx1adr/dr; ShhCre/+; 
Lmx1bf/f double mutant embryos (Yan et al., 2011). We are currently 
generating RNA-Seq data to compare transcriptome profiles of the 
midbrain between Lmx1a/b double mutant and wild-type E10.5 dpc 
embryos. We obtained a list of differentially expressed genes in 
Lmx1a/b double mutants (work in progress). We assessed if we could 
use the in vitro Lmx1a overexpression to validate these results. If the 
differences in gene expression that we see between the double 
mutants and wild-type embryos are due to the lack of expression of 
Lmx1a, we wanted to check what happens in an in-vitro model system 
that overexpresses Lmx1a.  
Neural progenitors deriving from Nes-Lmx1a cell line at d5 of 
differentiation show high levels of Lmx1a compared to wild-type cells 
and based in Otx2 expression levels the number of midbrain dopamine 
progenitors between wild-type cells and Nes-Lmx1a is the same. We 
therefore decided to test and validate some of the potential Lmx1a 
target using d5 cells RNA  
We picked some genes from RNA-Seq based on GO term analysis.  
Among the up-regulated genes were, Dmrtb1, Ppp2r2b, Cbln1 and 
Apcdd1 whereas Rspo2, Aldh1A1 and Megf10 were strongly 
downregulated. 
Of the downregulated genes tested, only Rspo2 and Aldh1a1 were 
differentially expressed in NesE-Lmx1a cells compared to WT and 
were upregulated as expected whereas Megf10 was not significantly 
affected. 
On the other hand, Apcdd1 and Ppp2r2b were significantly 
upregulated (and not downregulated as hypothetised) suggesting the 
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possibility that Lmx1a regulates these genes in a dose dependent 
manner (Fig 18). Importantly we could confirm up-regulation of Rspo2, 
Aldha1, (Fig.17). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 17. Aldh1a1 and Rspo2 are upregulated in NesE-Lmx1a cells at d5 MD 
cultures. Results of qPCR analysis performed at d5 MD confirm upregulation of 
Rspo2 and Aldh1a1. Values are presented as mean ± SEM (ns-statistically non 
significant, * p<0.05, relative to E14 -PD controls). 
 
 
 
 
 
 
 
 
 
____________________________________________________________RESULTS 
 37 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 18. Analysis of RNAseq downregulated genes. RT-qPCR performed on 
NesE-Lmx1a and E14 d5 MD cultures show upregulation of Apcdd1 and Pp2r2b, while 
Cbln1 and Dmrtb1 seems unaffected. Values are presented as mean ± SEM (ns-non 
significant, * p<0.05, relative to E14 Tg2a no PD controls). 
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4. Discussion 
 
Parkinson’s disease is a devastating neurological disorder with rising 
incidence worldwide. Treatment options are limited and focus mainly 
on alleviating the pathological symptoms rather than treating the cause 
of disease. This is mainly due to our lack of understanding what is 
actually driving this disease. The start of intensive research on 
midbrain dopamine neurons can be dated back to the mid twentieth 
century when degeneration of midbrain dopamine neurons was 
identified as main cause of Parkinson’s disease. Since this discovery, 
much effort has been expended in cell replacement therapies to 
compensate for the loss of dopamine neurons. Even though implants 
of mesencephalic fetal tissue showed to have a beneficial effect on 
patients, there are several moral and ethical issues correlated with the 
use of fetal tissue. Furthermore, the amount of fetal mesenecephalic 
tissue is limited, thus this source cannot be used for a wide range of 
patients. Nowadays stem cells are exploited as a potential infinite 
source for mDA neurons. Even if we are now able to differentiate stem 
cells into mDA neurons, we constantly need to improve our 
understanding in the differentiation process in order to improve its 
specificity and efficiency. 
In this work we highlight the role of Lmx1a expression in the 
specification of mDA neurons in vitro. We showed that Lmx1a 
positively regulates different genes involved in mDA neuron 
proliferation, specification and differentiation. 
Many studies have suggested a role for Lmx1a in mDA neuronal 
development. This was shown by loss-and-gain of function studies in 
chick embryos (Andersson et al., 2006) and by analyzing markers in 
Lmx1a dreher mice (Ono et al., 2007; Yan et al., 2011). In addition, an 
essential role of Lmx1a in dopaminergic differentiation of stem cell has 
_________________________________________________________DISCUSSION 
 39 
been described (Andersson et al., 2006; Chung et al., 2009; Sanchez-
Danes et al., 2012). 
Despite these increasing evidences that Lmx1a acts as an intrinsic 
determinant for mDA neuron development, the molecular mechanisms 
through which Lmx1a promotes dopaminergic specification and 
differentiation are still unclear. In order to unravel the molecular 
programming activated by Lmx1a we performed an in vivo 
transcriptome analysis by using Lmx1a/Lmx1b double mutants 
embryonic mDA brain areas. 
In vivo transcriptome analysis showed that several genes were 
significantly upregulated or downregulated in Lmx1a/Lmx1b double 
mutants. In this work we wanted to find an in vitro system to further 
validate the results from the in vivo transcriptome analysis. Lmx1a 
expression under the control of Tet-ON system would have been the 
best way to look at the downstream target of Lmx1a at different 
timepoints of differentiation. That system would have allowed us also 
to test the hypothesis if Lmx1a has a role in mature dopamine 
neurons. We generated transgenic ES cell lines that express Lmx1a 
mRNA and protein upon doxycycline induction. Unfortunately these 
cell lines do not express Lmx1a protein at the EpiSC stage, although 
Lmx1a mRNA is ten fold upregulated compared to control cell lines. 
We still don’t know the reason for this unexptected finding.  
Nes-Lmx1a cell line limited our analysis of Lmx1a role in the 
development of mDA only neurons in neural progenitors stage, as 
Lmx1a coding sequence in this cell line is under the control of Nestin 
enhancer (expressed in progenitor d3-d7 in vitro differentiation). 
Importantly we revealed that Lmx1a upregulates genes such as Ngn2, 
Foxa2. The positive regulation of Ngn2 from Lmx1a has been 
previously shown (Andersson et al., 2006). As far as we know, an 
Lmx1a dependent regulation of Foxa2 hasn’t been reported until today. 
We know that the Foxa2 upregulation is not due to an increase in the 
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number of dopamine progenitor cells as we couldn’t detect any 
significant difference in the transcript levels of Otx2. Here we 
hypothesize for the first time that Lmx1a may act synergistically with 
Shh signaling pathway to regulate Foxa2 expression. To test if Lmx1a 
can directly regulate Foxa2 expression, Chromatin Immunoprecitation 
(CHIP) experiments can be performed. No ChIP grade Lmx1a are 
available to date, therefore, we generated a FLAG-HA-Lmx1a mice to 
allow us to us FLAG or HA antibodies to assess this question. 
In Nes-Lmx1a cell line Nurr1 expression is strongly upregulated at d5 
of MD. Together with high fold-change downregulation of its transcript 
levels in the microarray study and qPCR analysis performed in Lmx1a 
dreher mutant (Hoekstra et al., 2013) strongly indicates that this key 
mDA factor is a downstream target of Lmx1a. Therefore the robust 
generation of Tuj1+ positive neurons that coexpress TH from in vitro 
differentiation of cell lines that express Lmx1a are probably a 
consequence of affected Nurr1 expression. 
Like Nurr1, Rspo2 gene expression levels were also upregulated at d5 
of MD in Nes-Lmx1a neural progenitor cells. Rspo2 belong to the 
group of R-spondins, a family of secreted proteins that activate Wnt/b-
catenin signaling (Han et al., 2011; Yoon et al., 2012).  Interestingly it 
was shown that all four R-spondin members regulate Wnt signaling at 
the level of Frizzled8 and Lrp6 receptors (Nam et al., 2006; Kim et al., 
2008). Another study reported that Rspo2 modulates Wnt signaling in 
mouse mammary epithelial cells, and that Rspo2 and Wnt1 act 
synergistically in the b-catenin pathway (Klauzinska et al., 2012). 
Intringuingly Wnt1 is important for patterning and proliferation of 
midbrain neuronal field (Megason et al., 2002) and several studies 
suggested a role of Lmx1a together with Wnt1 in mDA neuron 
differentiation. A novel Wnt1-Lmx1a autoregulatory loop was identified 
during mDA differentiation of ES cells (Chung et al., 2009). From our 
lab it was described that the reduced number of mDA progenitors in 
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Lmx1a dr/dr and Lmx1a/Lmx1b double mutants may be a 
consequence of proliferation and an increase in cell cycle exit of 
progenitors (Yan et al., 2011). We also showed that Wnt1 expression 
was slightly reduced in Lmx1a dr/dr, and specifically lost in the 
Lmx1a/Lmx1b double mutants suggesting that both genes specifically 
and redundantly regulate Wnt1 expression in mDA domain. Microarray 
study in mDA domain of Lmx1a dr/dr (Hoekstra et al., 2013) and RNA 
Seq analysis from midbrain sections of Lmx1a/Lmx1b double mutants 
(Ang’s lab, data not shown) have shown that the levels of Rspo2 
transcript are severely down-regulated. Our data in vitro validate the 
results of these two studies and are in line with what has been 
previously published. In their findings Hoekstra and colleagues have 
speculated that the lack of Rspo2 protein in the affected neurons of the 
Lmx1a dr/dr mutant might induce the previously suggested early cell-
cycle exit and premature differentiation.  
We also found that Slit2 transcript levels were significantly enhanced in 
d5 Nes-Lmx1a neural progenitors. The secreted Slit proteins control a 
large number of cellular processes, including cell migration and axon 
guidance, via their binding to Roundabout (Robo) receptors (Nguyen-
Ba-Charvet et al., 2004). In particular, Slits and Robos control 
evolutionarily guidance decisions during ventral midline crossing and 
positional of longitudinal tracts, via a repulsive activity (Plump et al., 
2002; Bielle et al., 2011). Moreover Slit2 has previously shown to 
regulate the position of ascending dopaminergic fibers projecting into 
the forebrain (Dugan et al., 2010). In addition Slit 2 mRNA levels were 
slightly decreased in E.12.5 Lmx1dr/dr and severely affected in 
Lmx1a/Lmx1b double mutants. (Yan et al., 2011). These findings 
suggested that Lmx1a and Lmx1b may be involved in regulating axon 
targeting of mDA neurons through regulating the expression of Slit2 in 
the floor plate. Our recent data strongly support the results previously 
published by the lab. 
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Midbrain dopaminergic fibers express Slit 2 receptor, Robo1 (Dugan et 
al., 2010). In vivo Lmx1a gain-of-function would be an interesting tool 
to see if ascending mDA neurons projection are altered.  
Another floor plate gene which was regulated in vitro regulated by 
Lmx1a was Arx1 and this is consistent with what has been previously 
published (Yan et al., 2011). 
At d9 of differentiation we found that several mRNA levels of 
differentiation markers such as Tuj1 and Nurr1 were up-regulated. We 
couldn’t detect up-regulation in mRNA levels of TH or Pitx3.  
Lmx1a regulates different processes of mDA development such as 
proliferation, specification and differentiation and these processes 
should happen at precise developmental stages An intriguing question 
is: Which are the molecular mechanisms that control the temporal 
specificity of Lmx1a action? Is Lmx1a cooperating with other protein 
complexes which regulate Lmx1a specifity for different targets, in 
distinct developmental stages? Trying to identify Lmx1a protein 
partners by Co-immunoprecipitation will be very useful to shed light on 
this hypothesis. 
Another hypothesis of Lmx1a mechanism of action is that Lmx1a 
induces transcription cascades. This hypothesis can be tested in vivo 
using Lmx1a flox alleles. Using Flp/flox  system we can stop Lmx1a 
expression at E10.5 and to check if this frame-time of expression is 
enough for the specification and differentiation of mDA neurons. 
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Figure 19. A model integrating different identified targets of Lmx1a. Lmx1a 
regulates mDA neuron identity, differentiation and mDA neuron axon targeting by 
respectively regulating Rspo2, Nurr1 and Slit2.(modified from Hoekstra et al., 2013). 
 
Since with this in vitro model system we could validate only some 
genes from the RNAseq results, our current understanding is that an in 
vitro system isn’t the best solution. Currently we are trying to validate 
using wild type versus mutant tissues instead.   	  
________________________________________________ACKNOWLEDGEMENTS 
 44 
5. Acknowledgements 
 
It wouldn’t have been possible to write this master thesis without the 
help and support of the kind people around me, to only some of whom 
it is possible to give particular mention here. 
I would like to express my gratitude to my supervisor Dr. Siew-Lan Ang 
for giving me the opportunity to be part of her research team and for 
her constant encouragement, support, and invaluable suggestions.  
The good advice, support and friendship of my second supervisor, 
Prof. Massimo Pasqualetti, has been invaluable on both an academic 
and a personal level, for which I am extremely grateful. 
My sincere thanks go to all the member of research team Suzanne 
Claxton, Wei Lin, Kamal Bouhali, Alessandro Pristera, Shabana Khan 
and Josephine Tang. A special thank you goes to Kamal for his 
patience, advices and support during the whole project.  
I would like to acknowledge Mina Agouti for her technical help in my 
experiments. I am grateful to Sara Migliarini who cultivated in me the 
love for science. 
I am deeply and forever indebted to my parents who brought me to this 
world and have been always beside me helping me psychologically, 
emotionally and materially to overcome all the possible obstacles. I 
also want to thank you all the members of my big family for their 
unconditional love.  
I thank you my friends for being with me in my happiest and saddest 
days. 
A last thank you but no less important goes to Gezim, my fiancé and 
best friend for supporting me in all my decisions, no matter how difficult 
they were for both of us.  	  
________________________________________________________REFERENCES 
 45 
6. References 
 
Andersson, E., Tryggvason, U., Deng, Q., Friling, S., Alekseenko, 
Z., Robert, B., Perlmann, T., Ericson, J. (2006). Identification of 
intrinsic determinants of midbrain dopamine neurons. Cell. 124(2), 
393-405. 
 
Ang, S. L. (2006). Transcriptional control of midbrain dopaminergic 
neuron development. Development.133(18), 3499-3506 
 
Bagri, A., Marín, O., Plump, A. S., Mak, J., Pleasure, S. J., 
Rubenstein, J. L., Tessier-Lavigne, M. (2002). Slit proteins prevent 
midline crossing and determine the dorsoventral position of major 
axonal pathways in the mammalian forebrain. Neuron. 33(2), 233-248. 
 
Baron, O., Förthmann, B., Lee, Y. W., Terranova, C., Ratzka, A., 
Stachowiak, E. K., Grothe, C., Claus, P., Stachowiak, M. K. (2012). 
Cooperation of nuclear fibroblast growth factor receptor 1 and Nurr1 
offers new interactive mechanism in postmitotic development of 
mesencephalic dopaminergic neurons. J Biol Chem. 287(24), 19827-
19840. 
 
Bielle, F., Marcos-Mondejar, P., Keita, M., Mailhes, C., Verney, C., 
Nguyen Ba-Charvet, K., Tessier-Lavigne, M., Lopez-Bendito, G., 
Garel, S. (2011). Slit2 activity in the migration of guidepost neurons 
shapes thalamic projections during development and evolution. 
Neuron. 69(6) 1085-109. 
 
Bjorklund, A. and Dunnett, S. B. (2007). Dopamine neuron systems in 
the brain: an update. Trends Neurosci 30(5), 194-202. 
 
Braak, H., Bohl, J. R., Müller, C. M., Rüb, U., de Vos, R. A., Del 
Tredici, K. (2006). Stanley Fahn Lecture 2005: The staging procedure 
for the inclusion body pathology associated with sporadic Parkinson's 
disease reconsidered. Mov Disord. 21(12), 2042-2051. 
 
Brodski, C., Weisenhorn, D., M., Signore, M., Sillaber, I., 
Oesterheld, M., Broccoli, V., Acampora, D., Simeone, A., Wurst, W. 
(2003). Location and size of dopaminergic and serotonergic cell 
________________________________________________________REFERENCES 
 46 
populations are controlled by the position of the midbrain-hindbrain 
organizer. J Neurosci. 23(10), 4199-4207. 
 
Cai, J., Donaldson, A., Yang, M., German, M. S., Enikolopov, G., 
Jacovitti, L. (2009). The role of Lmx1a in the differentiation of human 
embryonic stem cells into midbrain dopamine neurons in culture and 
after transplantation into a Parkinson's disease model. Stem Cells. 
27(1), 220-229. 
 
Chizhikov, V., Steshina, E., Roberts, R., Ilkin, Y., Washburn, L., 
Millen, K. J. (2006). Molecular definition of an allelic series of 
mutations disrupting the mouse Lmx1a (dreher) gene. Mamm 
Genome. 17(10), 1025-1032. 
 
Chung, S., Kim, C.H.,Kim, K. S. (2012). Lmx1a regulates dopamine 
transporter gene expression during ES cell differentiation and mouse 
embryonic development. J Neurochem. 122(2), 244-250. 
 
Chung, S., Leung, A., Han, B. S., Chang, M. Y., Moon, J. I., Kim, C. 
H., Hong, S.,Pruszak, J., Isacson, O.,Kim, K. S. (2009). Wnt1-lmx1a 
forms a novel autoregulatory loop and controls midbrain dopaminergic 
differentiation synergistically with the SHH-FoxA2 pathway. Cell Stem 
Cell. 5(6), 646-658. 
 
Dahlstroem, A. and Fuxe, K. (1964). Evidence for the existence of 
monoamine containing neurons in the central nervous system. I. 
Demonstration of monoamines in the cell bodies of brain stem 
neurons. Acta Physiol Scand Suppl pp. SUPPL 232:1-SUPPL 232:55. 
 
Dailly, E., Chenu, F., Renard, C. E., Bourin, M. (2004). Dopamine, 
depression and antidepressants. Fundam Clin Pharmacol. 18(6), 601-
607. 
 
Dugan, J. P., Stratton, A., Riley, H. P., Farmer, W. T., Mastick, G. S. 
(2011). Midbrain dopaminergic axons are guided longitudinally through 
the diencephalon by Slit/Robo signals. Mol Cell Neurosci. 46(1), 347-
356. 
 
________________________________________________________REFERENCES 
 47 
Falconer, D. S. and Sierts-Roth, U. (1951). Dreher, a new gene of 
the waltzer-shaker group in the house mouse. Z Indukt Abstamm 
Vererbungsl. 84(2), 71-73. 
 
Ferri, A. L., Lin, W., Mavromatakis, Y. E., Wang, J. C., Sasaki, H., 
Whitsett, J. A., Ang, S. L. (2007). Foxa1 and Foxa2 regulate multiple 
phases of midbrain dopaminergic neuron development in a dosage-
dependent manner. Development. 134(15), 2761-2769. 
 
Filippi, A., Dürr, K., Ryu, S., Willaredt, M., Holzschuh, J., Driever, 
W. (2007). Expression and function of nr4a2, lmx1b, and pitx3 in 
zebrafish dopaminergic and noradrenergic neuronal development. 
BMC Dev Biol. 7, 135. 
 
Friling, S., Andersson, E., Thompson, L. H., Jönsson, M. E., 
Hebsgaard, J.B., Nanou, E., Alekseenko, Z., Marklund, U., 
Kjellander, S., Volakakis N., Hovatta, O., El Manira, A., Björklund, 
A.,Perlmann T, Ericson, J. (2009) Efficient production of 
mesencephalic dopamine neurons by Lmx1a expression in embryonic 
stem cells. Proc Natl Acad Sci U S A. 106(18), 7613-7618. 
 
Gale, E. and Li, M. (2008). Midbrain dopaminergic neuron fate 
specification: Of mice and embryonic stem cells. Mol Brain.1:8. 
 
Galvan, A. and Wichmann, T. (2008). Pathophysiology of 
parkinsonism. Clin Neurophysiol. 119(7), 1459-1474. 
 
Gennet, N., Gale, E., Nan, X., Farley, E., Takacs, K., Oberwallner, 
B., Chambers, D., Li. M. (2011). Doublesex and mab-3-related 
transcription factor 5 promotes midbrain dopaminergic identity in 
pluripotent stemcells by enforcing a ventral-medial progenitor fate. 
Proc Natl Acad Sci U S A. 108(22), 9131-9136.  
 
Gerfen, C. R., Engber, T. M., Mahan, L. C., Susel, Z., Chase, T. N., 
Monsma, F. J. Jr., Sibley, D. R. (1990). D1 and D2 dopamine 
receptor-regulated gene expression of striatonigral and striatopallidal 
neurons. Science. 250(4986), 1429-1432. 
 
________________________________________________________REFERENCES 
 48 
Gossen, M., Freundlieb, S., Bender, G., Müller, G., Hillen, 
W.,Bujard, H. (1995). Transcriptional activation by tetracyclines in 
mammalian cells. Science. 268(5218), 1766-1769. 
 
Han, X. H., Jin, Y. R., Seto, M., Yoon, J. K. (2011). A WNT/beta-
catenin signaling activator, R-spondin, plays positive regulatory roles 
during skeletal myogenesis. J Biol Chem. 286(12), 10649-10659.  
 
Hoekstra, E. J., von Oerthel, L., van der Heide, L. P., 
Kouwenhoven, W. M., Veenvliet, J. V., Wever, I., Jin, Y. R., Yoon, 
J. K., van der Linden, A. J., Holstege, F. C., Groot Koerkamp, M. J, 
Smidt M. P. (2013). Lmx1a encodes a rostral set of mesodiencephalic 
dopaminergic neurons marked by the Wnt/B-catenin signaling activator 
R-spondin 2. PLoS One. 8(9), e74049. 
 
Jaeger I., Arber, C., Risner-Janiczek, J. R., Kuechler, J., Pritzsche, 
D., Chen, I C., Naveenan, T., Ungless, M. A., Li, M. (2011). 
Temporally controlled modulation of FGF/ERK signaling directs 
midbrain dopaminergic neural progenitor fate in mouse and human 
pluripotent stem cells. Development. 138(20), 4363-4374. 
 
Jonsson, G. (1967). Fluorescence methods for the histochemical 
demonstration of monoamines. VII. Fluorescence studies on biogenic 
monoamines and related compounds condensed with formaldehyde. 
Histochemie 8(3), 288-296. 
 
Kele, J., Simplicio, N., Ferri, A. L., Mira, H., Guillemot, F., Ang, S. 
L. (2006). Neurogenin 2 is required for the development of ventral 
midbrain dopaminergic neurons. Development. 133(3), 495-505. 
 
Kelley, A. E. and Berridge, K. C. (2002). The neuroscience of natural 
rewards: relevance to addictive drugs. J Neurosci. 22(9), 3306-3311. 
 
Kim, K. A., Wagle, M., Tran K, Zhan, X., Dixon, M. A., Liu, S., Gros, 
D., Korver, W., Yonkovich, S., Tomasevic, N., Binnerts, M., Abo, A. 
(2008). R-Spondin family members regulate the Wnt pathway by a 
common mechanism. Mol Biol Cell. 19(6):2588-2596. 
 
Klauzinska, M., Baljinnyam, B., Raafat, A., Rodriguez-Canales, J., 
Strizzi, L., Greer, Y. E., Rubin, J.S., Callahan, R. (2012). Rspo2/Int7 
________________________________________________________REFERENCES 
 49 
regulates invasiveness and tumorigenic properties of mammary 
epithelial cells. J Cell Physiol. 227(5), 1960-1971.  
 
Lin, W., Metzakopian, E., Mavromatakis, Y. E., Gao, N., Balaskas, 
N., Sasaki, H., Briscoe, J., Whitsett J. A., Goulding, M., Kaestner, 
K. H., Ang, S.L. (2009). Foxa1 and Foxa2 function both upstream of 
and cooperatively with Lmx1a and Lmx1b in a feedforward loop 
promoting mesodiencephalic dopaminergic neuron development. Dev 
Biol. 333(2), 386-396. 
 
Lindvall, O. and Björklund, A. (2011). Cell therapeutics in 
Parkinson’s disease.’, Neurotherapeutics. 8(4), 539–548. 
 
Lyons, J.P., and Wahlsten, D. (1988). Postnatal development of brain 
and behavior of shaker short-tail mice. Behav Genet. 18(1), 35-53. 
 
Megason, S. G. and McMahon, A. P. (2002). A mitogen gradient of 
dorsal midline Wnts organizes growth in the CNS. Development. 
129(9), 2087-2098. 
 
Metzakopian, E., Lin, W., Salmon-Divon, M., Dvinge, H., 
Andersson, E., Ericson, J., Perlmann, T., Whitsett, J. A., Bertone. 
P., Ang, S. L. (2012). Genome-wide characterization of Foxa2 targets 
reveals upregulation of floor plate genes and repression of 
ventrolateral genes in midbrain dopaminergic progenitors. 
Development. 139(14), 2625-2634. 
 
Millonig, J. H., Millen, K. J., Hatten, M.E. (2000). The mouse Dreher 
gene Lmx1a controls formation of the roof plate in the vertebrate CNS. 
Nature. 403(6771), 764-769. 
 
Nam, J. S., Turcotte, T. J., Smith, P. F., Choi, S., Yoon, J. K. (2006). 
Mouse cristin/R-spondin family proteins are novel ligands for the 
Frizzled 8 and LRP6 receptors and activate beta-catenin-dependent 
gene expression. J Biol Chem. 281(19), 13247-13257. 
 
Nguyen-Ba-Charvet, K. T., Picard-Riera, N., Tessier-Lavigne, 
M.,Baron-Van Evercooren, A., Sotelo, C., Chédotal, A. (2004). 
Multiple roles for slits in the control of cell migration in the rostral 
migratory stream. J Neurosci. 24(6), 1497-1506. 
________________________________________________________REFERENCES 
 50 
 
Nunes, I., Tovmasian, L. T., Silva, R. M., Burke, R. E., Goff, S. P. 
(2003). Pitx3 is required for development of substantia nigra 
dopaminergic neurons. Proc Natl Acad Sci U S A. 100(7), 4245-4250. 
 
Olanow, C. W. and Brundin, P. (2013). Parkinson's disease and 
alpha synuclein: is Parkinson's disease a prion-like disorder?. Mov 
Disord. 28(1), 31-40. 
 
Ono, Y., Nakatani, T., Sakamoto, Y., Mizuhara, E., Minaki, Y., 
Kumai, M., Hamaguchi, A., Nishimura, M., Inoue, Y., Hayashi, H., 
Takahashi, J., Imai, T. (2007). Differences in neurogenic potential in 
floor plate cells along an anteroposterior location: midbrain 
dopaminergic neurons originate from mesencephalic floor platecells. 
Development. 134(17), 3213-3225. 
 
Plump, A.S., Erskine, L., Sabatier, C., Brose, K., Epstein, C. J., 
Goodman, C. S., Mason, C. A., Tessier-Lavigne, M. (2002). Slit1 
and Slit2 cooperate to prevent premature midline crossing of retinal 
axons in the mouse visual system. Neuron. 33(2), 219-232. 
 
Puelles, E., Acampora, D., Lacroix, E., Signore, M., Annino, A., 
Tuorto, F., Filosa, S., Corte, G., Wurst, W., Ang, S. L., Simeone, A. 
(2003). Otx dose-dependent integrated control of antero-posterior and 
dorso-ventral patterning of midbrain. Nat Neurosci. 6(5), 453-460. 
 
Puelles, E., Annino, A., Tuorto, F.,Usiello, A., Acampora, D., 
Czerny, T., Brodski C., Ang, S. L., Wurst, W., Simeone, A. (2004). 
Otx2 regulates the extent, identity and fate of neuronal progenitor 
domains in the ventral midbrain. Development. 131(9), 2037-2048. 
 
Sánchez-Danés, A., Consiglio, A., Richaud, Y., Rodríguez-Pizà, I., 
Dehay, B., Edel, M., Bové, J., Memo, M., Vila, M.,Raya, A., Izpisua 
Belmonte, J. C. (2012). Efficient generation of A9 midbrain 
dopaminergic neurons by lentiviral delivery of LMX1A in human 
embryonic stem cells and induced pluripotent stemcells. Hum Gene 
Ther. 23(1), 56-69. 
Sesack, S. R.  and Carr, D. B. (2002). Selective prefrontal cortex 
inputs to dopamine cells: implications for schizophrenia. Physiol 
Behav. 77(4-5), 513-517. 
________________________________________________________REFERENCES 
 51 
 
Simon, H. H., Saueressig, H., Wurst, W., Goulding, M. D., O'Leary, 
D. D. (2001). Fate of midbrain dopaminergic neurons controlled by the 
engrailed genes. J Neurosci 21(9), 3126-3134. 
 
Smidt, M. P., Asbreuk, C.H., Cox, J.J., Chen, H., Johnson, R. L., 
Burbach. J.P. (2000). A second independent pathway for 
development of mesencephalic dopaminergic neurons requires Lmx1b. 
Nat Neurosci.	  3(4),337-341. 
 
Southern, E. (2006). Southern blotting. Nat Protoc.1(2), 518-525. 
 
Thomas, B. and Beal, M. F. (2007). Parkinson's disease. Hum Mol 
Genet. 16 Spec No. 2, R183-R194. 
 
Tzschentke, T. M and Schmidt, W. J. (2000). Functional relationship 
among medial prefrontal cortex, nucleus accumbens, and ventral 
tegmental area in locomotion and reward. Crit Rev Neurobiol.14(2), 
131-142. 
 
Vernay, B., Koch, M., Vaccarino, F., Briscoe, J., Simeone, A., 
Kageyama, R., Ang, S.L. (2005). Otx2 regulates subtype specification 
and neurogenesis in the midbrain. J Neurosci. 25(19), 4856-4867. 
 
Wichmann, T., DeLong, M. R., Guridi, J., Obeso, J. A. (2011). 
Milestones in research on the pathophysiology of Parkinson's disease. 
Mov Disord. 26(6), 1032-1041. 
 
Wightman, R. M. and Robinson, D. L. (2002). Transient changes in 
mesolimbic dopamine and their association with 'reward'. J 
Neurochem. 82(4), 721-735. 
 
Yan, C. H., Levesque, M., Claxton, S., Johnson. R.L., Ang, S.L. 
(2011). Lmx1a and lmx1b function cooperatively to regulate 
proliferation, specification, and differentiation of midbrain dopaminergic 
progenitors. J Neurosci. 31(35), 12413-12425. 
 
Yoon, J. K. and Lee, J. S. (2012). Cellular signaling and biological 
functions of R-spondins. Cell Signal. 24(2), 369-377. 	  
